Elevance Health, Inc. (ELV) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for ELV. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 1,592 institutions reported holding ELV, with 197.3 million shares worth $76.0 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Vanguard | 22,508,285 | $8.7B | DECREASED |
| BlackRock | 18,991,090 | $7.3B | DECREASED |
| State Street | 10,426,610 | $4.0B | INCREASED |
| Wellington Management | 9,213,513 | $3.6B | INCREASED |
| Sanders Capital | 5,825,024 | $2.3B | DECREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Mark Kaye (EVP & CFO) | SELL | 273 | $122K | 2026-10-22 |
| Mark Kaye (EVP & CFO) | SELL | 827 | $369K | 2026-10-22 |
| Mark Kaye (EVP & CFO) | SELL | 160 | $71K | 2026-10-22 |
| Mark Kaye (EVP & CFO) | SELL | 440 | $195K | 2026-10-22 |
| Mark Kaye (EVP & CFO) | SELL | 480 | $212K | 2026-10-22 |
Full institutional holdings, insider history, and congressional trades for Elevance Health, Inc. on SentiSense.